These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36346944)

  • 1. Identification of PHB2 as a Potential Biomarker of Luminal A Breast Cancer Cells Using a Cell-Specific Aptamer.
    Liu M; Wang Z; Li S; Deng Y; He N
    ACS Appl Mater Interfaces; 2022 Nov; 14(46):51593-51601. PubMed ID: 36346944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise discrimination of Luminal A breast cancer subtype using an aptamer in vitro and in vivo.
    Liu M; Zhang B; Li Z; Wang Z; Li S; Liu H; Deng Y; He N
    Nanoscale; 2020 Oct; 12(38):19689-19701. PubMed ID: 32966497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
    Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
    Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells.
    Liu M; Yang T; Chen Z; Wang Z; He N
    Biomater Sci; 2018 Nov; 6(12):3152-3159. PubMed ID: 30349922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
    Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
    Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
    Zhang WY; Chen HL; Chen QC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.
    Speransky S; Serafini P; Caroli J; Bicciato S; Lippman ME; Bishopric NH
    Breast Cancer Res Treat; 2019 Jul; 176(2):271-289. PubMed ID: 31006104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
    Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
    Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy.
    Qiao Y; Shi Y; Ji M; Wang Z; Bai X; Zhang K; Yin K; Zhang Y; Chen X; Zhang Y; Lu J; Zhao J; Liu K; Yuan B
    Int J Biol Macromol; 2024 Feb; 259(Pt 1):129002. PubMed ID: 38176501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
    Sett A; Borthakur BB; Bora U
    Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer selection and applications for breast cancer diagnostics and therapy.
    Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
    J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the target protein of the metastatic colorectal cancer-specific aptamer W3 as a biomarker by aptamer-based target cells sorting and functional characterization.
    Li W; Wu CC; Wang S; Zhou L; Qiao L; Ba W; Liu F; Zhan L; Chen H; Yu JS; Fang J
    Biosens Bioelectron; 2022 Oct; 213():114451. PubMed ID: 35700603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of aptamers against triple negative breast cancer cells using high throughput sequencing.
    Ferreira D; Barbosa J; Sousa DA; Silva C; Melo LDR; Avci-Adali M; Wendel HP; Rodrigues LR
    Sci Rep; 2021 Apr; 11(1):8614. PubMed ID: 33883615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an enriched pool of DNA aptamers for an HER2-overexpressing cell line selected by Cell SELEX.
    Dastjerdi K; Tabar GH; Dehghani H; Haghparast A
    Biotechnol Appl Biochem; 2011; 58(4):226-30. PubMed ID: 21838796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation.
    Song Z; Mao J; Barrero RA; Wang P; Zhang F; Wang T
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer protein biomarker discovery based on nucleic acid aptamers.
    Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
    Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
    Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
    Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
    Liu Z; Duan JH; Song YM; Ma J; Wang FD; Lu X; Yang XD
    J Transl Med; 2012 Jul; 10():148. PubMed ID: 22817844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.
    Wu J; Wang C; Li X; Song Y; Wang W; Li C; Hu J; Zhu Z; Li J; Zhang W; Lu Z; Yang CJ
    PLoS One; 2012; 7(9):e46393. PubMed ID: 23029506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.